SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents is a research paper published in Pharmaceuticals (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: HHSN261201700037C, R01DK57690, R01CA158372, R21NS095047, 2UL1TR001425-05A1
University of Cincinnati
Grant: Brain Tumor Molecular Therapeutics program pilot grant, Bearcats against Cancer grant, and Hematology-Oncology programmatic support
National Institutes of Health
Grant: 5R01DK057690-04
STUDY OF SAPOSINS BIOLOGICAL FUNCTIONS
National Institutes of Health
Grant: 2UL1TR001425-05A1
Center for Clinical and Translational Science and Training
National Institutes of Health
Grant: 5R21NS095047-02
Intravenous Enzyme Replacement Therapy for CNS Disorders
National Institutes of Health
Grant: 5R01CA158372-04
Acidic Phospholipid-Selective Treatment for Neuroblastoma
Fields of Study
Keywords
Sustainable Development Goals